Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
Matthew J. Frank, Patrick M. Reagan, Nancy L. Bartlett, et al.
Cancer Discovery (2018) Vol. 8, Iss. 10, pp. 1258-1269
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jérôme Galon, Daniela Bruni
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 197-218
Closed Access | Times Cited: 2614
Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 1085
Therapeutic cancer vaccines
Mansi Saxena, Sjoerd H. van der Burg, Cornelis J.M. Melief, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 360-378
Closed Access | Times Cited: 1076
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Martin McLaughlin, Emmanuel C. Patin, Malin Pedersen, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 203-217
Closed Access | Times Cited: 609
Cancer vaccines: the next immunotherapy frontier
Matthew J. Lin, Judit Svensson‐Arvelund, Gabrielle S. Lubitz, et al.
Nature Cancer (2022) Vol. 3, Iss. 8, pp. 911-926
Closed Access | Times Cited: 562
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 351
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Ignacio Melero, Eduardo Castañón, Maite Álvarez, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 9, pp. 558-576
Open Access | Times Cited: 341
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
Antoni Ribas, Theresa Medina, Shivaani Kummar, et al.
Cancer Discovery (2018) Vol. 8, Iss. 10, pp. 1250-1257
Open Access | Times Cited: 274
TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
Marina Luchner, Sören Reinke, Anita Milicic
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 142-142
Open Access | Times Cited: 207
Type I interferon-mediated tumor immunity and its role in immunotherapy
Renren Yu, Bo Zhu, Degao Chen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 188
Tumor-associated myeloid cells: diversity and therapeutic targeting
Alberto Mantovani, Federica Marchesi, Sébastien Jaillon, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 566-578
Open Access | Times Cited: 153
Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
Claire Vanpouille‐Box, Jules A. Hoffmann, Lorenzo Galluzzi
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 11, pp. 845-867
Closed Access | Times Cited: 147
Targeting innate immune pathways for cancer immunotherapy
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 73
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 63
Biomaterial‐Based In Situ Cancer Vaccines
Bo Yang, Hua Wang
Advanced Materials (2023) Vol. 36, Iss. 43
Open Access | Times Cited: 49
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao
Cells (2023) Vol. 12, Iss. 17, pp. 2147-2147
Open Access | Times Cited: 48
Intratumoral Immunotherapy for Early-stage Solid Tumors
Wan Xing Hong, Sarah Haebe, Andrew S. Lee, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 13, pp. 3091-3099
Open Access | Times Cited: 136
Intratumoral Immunotherapy—Update 2019
Omid Hamid, Rubina Ismail, Igor Puzanov
The Oncologist (2019) Vol. 25, Iss. 3, pp. e423-e438
Open Access | Times Cited: 134
Oncolysis without viruses — inducing systemic anticancer immune responses with local therapies
Oliver Kepp, Aurélien Marabelle, Laurence Zitvogel, et al.
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 1, pp. 49-64
Closed Access | Times Cited: 126
Chemical Strategies to Boost Cancer Vaccines
Wenhao Li, Yanmei Li
Chemical Reviews (2020) Vol. 120, Iss. 20, pp. 11420-11478
Closed Access | Times Cited: 126
Intratumoral Immunotherapy: From Trial Design to Clinical Practice
Stéphane Champiat, Lambros Tselikas, Siham Farhane, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 3, pp. 665-679
Open Access | Times Cited: 108
<p>Toll-Like Receptor 9 Agonists in Cancer</p>
Lilit Karapetyan, Jason J. Luke, Diwakar Davar
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 10039-10061
Open Access | Times Cited: 106
Directing Traffic: How to Effectively Drive T Cells into Tumors
Annabelle Anandappa, Catherine J. Wu, Patrick A. Ott
Cancer Discovery (2020) Vol. 10, Iss. 2, pp. 185-197
Open Access | Times Cited: 91
In situ cancer vaccination using lipidoid nanoparticles
Jinjin Chen, Min Qiu, Zhongfeng Ye, et al.
Science Advances (2021) Vol. 7, Iss. 19
Open Access | Times Cited: 91
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma
Victoria Atkinson, Adnan Khattak, Andrew Haydon, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001681-e001681
Open Access | Times Cited: 80
Page 1 - Next Page

Scroll to top